产品中心 抗体 功能性抗体

所有图片(1/1)

Invivo anti-human CD47 Recombinant mAb

Leukocyte surface antigen CD47,Antigenic surface determinant protein OA3,Integrin-associated protein (IAP),Protein MER6,MER6

价格 1,010.00 供应商现货 : 3-5个工作日
货号 S0B7031
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    CD47
  • 分子别名

    Leukocyte surface antigen CD47; Antigenic surface determinant protein OA3; Integrin-associated protein (IAP); Protein MER6; MER6
  • 细胞定位

    Cell membrane
  • Accession

    Q08722
  • 克隆号

    B6H12
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG1,k
  • 同型对照

    Invivo mouse IgG1 isotype control
  • 反应种属 ?

    Hu
  • 纯化方式

    Protein G
  • 浓度

    5 mg/ml
  • 纯度

    >95% (Determined by SDS-PAGE)
  • 内毒素含量

    <1EU/mg
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4, containing no preservative

  • 储存条件

    2 to 8 °C for 2 weeks under sterile conditions;
    -20 °C for 3 months under sterile conditions;
    -80 °C for 24 months under sterile conditions.
    Please avoid repeated freeze-thaw cycles.

  • 应用

    in vitro CD47 neutralization

    in vivo CD47 neutralization in human tumor xenograft models or humanized mice

    ELISA

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000 Hu
背景介绍
  • CD47, also known as integrin-associated protein, is a ubiquitously expressed cell surface receptor that belongs to the immunoglobulin superfamily. It is widely known for its role in preventing macrophage-mediated phagocytosis by interacting with signal regulatory protein alpha (SIRPα) on phagocytic cells. This “don’t eat me” signal is crucial for the survival of healthy cells, but cancer cells often overexpress CD47 to evade immune attack. In addition to its role in immune regulation, CD47 is involved in various cellular processes, including cell adhesion, migration, and the regulation of autophagy and cell death. For instance, it can regulate the migration of immune cells like neutrophils and dendritic cells, and its interaction with thrombospondin-1 (TSP-1) can induce apoptosis in certain cell types. Due to its significant role in cancer immunotherapy, CD47 has become an important target for developing new therapeutic strategies.

  • 免疫印迹

    • WB result of Invivo anti-human CD47 Recombinant mAb
      Primary antibody: Invivo anti-human CD47 Recombinant mAb at 1/1000 dilution
      Lane 1: CD47 His Tag Protein, Mouse 10 ng
      Lane 2: CD47 His Tag Protein, Human 10 ng
      Secondary antibody: Goat Anti-mouse IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 35 kDa
      Observed MW: 25-36 kDa

评论(0)